loader from loading.io

Joost Breeksema - The Interdisciplinary Conference on Psychedelic Research

Psychedelics Today

Release Date: 02/04/2020

PT 612 - Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning show art PT 612 - Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning

Psychedelics Today

In this wide-ranging conversation, journalist Mattha Busby joins Joe Moore to reflect on the shifting tone of the psychedelic movement in the wake of Psychedelic Science 2025. Based in Vancouver, Mattha has written for The Guardian, VICE, Esquire, TIME, and Wired, bringing a uniquely embedded yet critical lens to the space. They discuss the post-conference mood and the sense that the industry is sobering up—less hype, more introspection. Mattha reflects on the growing division between underground practitioners, activists, and biotech startups, and the importance of vision, ethics, and...

info_outline
PT 611 - Dylan Beynon - Mindbloom show art PT 611 - Dylan Beynon - Mindbloom

Psychedelics Today

Dylan Beynon: At-Home Ketamine Therapy, Big Pharma Pushback, and the Future of Psychedelic Accessibility In this episode, Joe Moore welcomes Dylan Beynon, CEO and Founder of , one of the largest providers of legal, at-home ketamine therapy in the U.S. Dylan shares the deeply personal story that led him to psychedelic medicine—including the tragic loss of his mother and sister to addiction and mental illness—and how these experiences continue to fuel his mission to make psychedelic therapy affordable and accessible for all. Mindbloom has now facilitated over 654,000 sessions across 38...

info_outline
PT 610 - Victoria Litman - The Future of Psychedelic Regulation Is Local show art PT 610 - Victoria Litman - The Future of Psychedelic Regulation Is Local

Psychedelics Today

In this episode, we sit down with ., to discuss why the future of psychedelic access in the United States is being shaped not by federal agencies, but by the bold actions of individual states. As a legal scholar and writer focusing on drug policy, Victoria breaks down the significance of the FDA’s 2024 rejection of psychedelic-assisted therapy, and why that decision might be less of a setback than it seems. We explore how state-level initiatives like Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act are setting the stage for a new model of access—one rooted...

info_outline
PT 609 - PS 25 Morning Show - Day Three show art PT 609 - PS 25 Morning Show - Day Three

Psychedelics Today

info_outline
PT 608 - PS 25 Morning Show - Day Two show art PT 608 - PS 25 Morning Show - Day Two

Psychedelics Today

info_outline
PS 25 - Morning Show Number 1 show art PS 25 - Morning Show Number 1

Psychedelics Today

Joe Moore and Anne Philippi are hosts of the PS25 Morning Show! This one features Dee Dee Goldpaugh, LCSW and Tommaso Barba, PhDC! We talk about all things Sex and Psychedelics!

info_outline
PT 606 - Ibogaine and the Future of Healing: Trevor Millar & Jonathan Dickinson of Ambio Life Sciences show art PT 606 - Ibogaine and the Future of Healing: Trevor Millar & Jonathan Dickinson of Ambio Life Sciences

Psychedelics Today

n this episode of Psychedelics Today, kicking of Psychedelic Science 2025 week in Denver, we sit down with Jonathan Dicksinson, Chief Executive Officer, and Trevor Millar, Chief Operations Officer of Ambio Life Sciences – one of the world’s leading ibogaine clinics – to explore the potential of ibogaine for addiction, neuroregeneration, and how ethics, honoring experience, and sustainability will be key to delivering ibogaine at scale.  Trevor shares his early work supporting marginalized populations in Vancouver’s Downtown Eastside, which led to the founding of Liberty Root, one...

info_outline
PT 605 - Jeff Breau - Exploring Psychedelic Churches at Harvard Divinity School show art PT 605 - Jeff Breau - Exploring Psychedelic Churches at Harvard Divinity School

Psychedelics Today

In this episode of Psychedelics Today, hosts sit down with Jeff Breau from Harvard Divinity School's Center for the Study of World Religions. Key themes include the intersection of psychedelics and religion, harm reduction practices, and the burgeoning psychedelic church movement. Jeff brings insights from his ethnographic research on psychedelic churches and discusses the importance of interdisciplinary collaboration for advancing understanding in this field. He also delves into the role of music in psychedelic therapy, critiques of the Mystical Experience Questionnaire (MEQ), and the...

info_outline
PT 604 - Paul Gillis-Smith - Psychedelics, Religion & Lisa Bieberman show art PT 604 - Paul Gillis-Smith - Psychedelics, Religion & Lisa Bieberman

Psychedelics Today

In this episode, Joe Moore sits down with  from to discuss a range of fascinating topics. They begin by discussing the Harvard Divinity School and the CSWR’s mission and history. The conversation delves into the work and legacy of , a pivotal figure in the 1960s psychedelic harm reduction movement. It explores her contributions to the field through her Psychedelic Information Center. They also touch on the Quaker traditions and their intersection with LSD use, showing how spirituality and psychedelics can coalesce. Paul also talks about upcoming psychedelic and chaplaincy workshops,...

info_outline
PT 603 - Dr Simon Ruffell - Other Ways of Knowing show art PT 603 - Dr Simon Ruffell - Other Ways of Knowing

Psychedelics Today

In this episode of Psychedelics Today, Joe Moore speaks with Dr. Simon Ruffell, a London-based psychiatrist, researcher, and curandero-in-training in the López Mahua lineage of the Shipibo tradition. Dr. Ruffell shares how his early fascination with psychiatry eventually led to a deep disillusionment with the limitations of conventional treatments—and a surprising pivot toward the Amazon. Now working at the intersection of Indigenous healing and clinical research, Ruffell describes his journey from medical school to shamanic apprenticeship. He offers insight into the Shipibo understanding...

info_outline
 
More Episodes

In this episode, Joe interviews Joost Breeksema from the Netherlands to talk about the Interdisciplinary Conference on Psychedelic Research. In the show they cover topics on ICPR 2020, and the importance of accessibility.

3 Key Points:

  1. The Interdisciplinary Conference on Psychedelic Research takes place April 24-26, 2020 in the Netherlands.
  2. It's important to acknowledge the indigenous, ethical, and political dimensions to psychedelic use at conferences.
  3. Although this conference will be catered toward mainstream science and research, personal experiences and stories are important too.

Support the show

Navigating Psychedelics


Show Notes

About Joost

  • Joost is a part of the OPEN Foundation
  • ICPR is a huge conference
    • Nobody before was doing research on psychedelics in the Netherlands
  • William James work sparked Joost’s interest in psychedelics

ICPR

  • Starting with the OPEN Foundation, the conference has been very scientific
    • It is interdisciplinary, but also taken very seriously
    • This field is so broad, you could really never get bored
  • Wade Davis, Alicia Danforth, Matt Johnson and more will be speaking at the conference
  • There will be over 80 speakers
  • Joost expects it to be a pretty international conference, half local, and half from abroad
  • Psychiatrists are usually short on time, and they like things compressed more
  • It's really easy and cheap to grow psilocybin as mushrooms or truffles
    • Even in Mexico, they need to use GMP Psilocybin

Accessibility

  • If this is going to be the treatment, how are we going to help people afford it?” - Joe
  • There is some tricky stuff happening, companies trying to patent different parts of psilocybin to use it for therapeutic use
  • Ketamine has been off patent for years, but you can develop a new route of administration, patent that, and make a ton of money
  • Spravato is making it to the UK

Conference Themes

  • Joost is both excited and scared that they are bringing indigenous practitioners to the conference
    • It's important to acknowledge the indigenous, ethical, and political dimensions to psychedelic use
    • Talking about concepts and approaches to healing is going to be an important aspect
    • The goal would be to do research with the indigenous communities to be able to address the needs of psychedelic use
  • There are also a few neuroimaging people coming
  • For mainstream scientists, the conference has to be as close to a scientific conference as possible, they may be turned off to the cultural aspects of psychedelics
    • It's the conservative nature of psychedelia
  • Joost also says that although the scientific research is important, it is really cool to hear the personal experiences
  • People’s experience with psychedelics may be completely different from each other
    • It's important to share the bad stories with the good stories
    • If we don't share the stories and data and research, then we can never learn
  • Joe hopes that there will be a growth of citizen science in the near future

Links

ICPR


About Joost

Joost Breeksema is a part of the OPEN Foundation, which from it came the Interdisciplinary Conference on Psychedelic Research. His current research focuses on the experiences of patients that are undergoing therapy assisted by psychedelic substances. His aim is to better understand psychological mechanisms of action/change, to tease out salient themes, and finally to learn about what works and what does not work in psychedelic-assisted psychotherapy.

Use code PSYTODAY at Onnit for a discount on all products except fitness equipment

Get a 30 day free audible trial at audibletrial.com/psychedelicstoday